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BM is one of most actively proliferating tissues 
of the body. In humans, 1011–1012 mature 
blood cells are generated per day (Gordon et al., 
2002) from short-lived highly proliferative he-
matopoietic progenitors which arise from a rare 
population of hematopoietic stem cells (HSCs) 
with multilineage differentiation and self-renewal 
capacity (Kondo et al., 2003). Transplantation 
studies in mice have shown that a single HSC 
is capable of reconstituting and maintaining all 
hematopoietic lineages in lethally irradiated re-
cipients for their respective lifetime (Osawa et al., 
1996a; Kiel et al., 2005), or even longer in assays 
of serial transplantation (Harrison and Astle, 
1982; Allsopp et al., 2003); however, physio-
logical hematopoiesis is at least oligoclonal at 
any given time, indicating that it is not main-
tained by offspring of one single HSC (Jordan 
and Lemischka, 1990; McKenzie et al., 2006). 
Adult BM provides a specialized microenvi-
ronment for HSCs, the so-called “niche,” that 
allows HSC maintenance at homeostatic levels. 
This process is controlled by both intrinsic 
and extrinsic signals, as demonstrated in mul-
tiple animal models with genetic alterations in 
nonhematopoietic and hematopoietic tissues 
(Orford and Scadden, 2008).
Steady-state HSC cycling kinetics have 
been evaluated by in vivo labeling assays with 
BrdU (Cheshier et al., 1999; Kiel et al., 2007) 
and biotin (Nygren and Bryder, 2008) and, in 
recent studies, using both BrdU labeling and 
histone 2B GFP (H2B-GFP) transgenic mouse 
models (Wilson et al., 2008; Foudi et al., 2009). 
BrdU and biotin labeling suggested that all 
HSCs divide, on average, every 17.8 d, whereas 
combined BrdU and H2B-GFP experiments 
revealed two HSC populations, one actively di-
viding about every 9–36 d and one dividing 
approximately every 56–145 d (Wilson et al., 
2008; Foudi et al., 2009). Assuming conserved 
division rates in these populations in steady 
state during a 2-yr laboratory mouse lifetime, 
the former experiments suggest that HSCs di-
vide 42×, whereas the latter suggest that one 
population would divide 20 times and the other 
5 times. This might imply that slow dividing 
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Hematopoietic stem cells (HSCs) maintain blood production. How often mouse HSCs divide 
and whether each HSC contributes simultaneously, sequentially, or repetitively to hemato-
poiesis remains to be determined. We track division of 5-(and-6)-carboxyfluorescein diac-
etate succinimidyl ester (CFSE)–labeled HSC in vivo. We found that, in steady-state mice, 
bone marrow cells capable of reconstituting lifelong hematopoiesis are found within both 
fast-cycling (undergoing five or more divisions in 7 wk) and quiescent (undergoing zero 
divisions in 12–14 wk) lineage marker–negative c-Kit+ Sca-1+ populations. The contribu-
tion of each population to hematopoiesis can fluctuate with time, and cells with extensive 
proliferative history are prone to return to quiescence. Furthermore, injection of the bacte-
rial component lipopolysaccharide increased the proliferation and self-renewal capacity of 
HSCs. These findings suggest a model in which all HSCs undergo dynamic and demand-
adapted entry into and exit out of the cell cycle over time. This may facilitate a similar 
degree of turnover of the entire HSC pool at the end of life.
© 2011 Takizawa et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
T
h
e 
Jo
u
rn
al
 o
f 
E
xp
er
im
en
ta
l 
M
ed
ic
in
e
274 Hematopoietic stem cell cycling dynamics | Takizawa et al.
Also, some cytokines produced by immune cells in response 
to viral or bacterial infection can activate quiescent HSC 
(Essers et al., 2009; Sato et al., 2009; Baldridge et al., 2010). 
However, it is thus far unclear if these naturally occurring 
stimulants trigger only differentiation or also accelerated HSC 
self-renewal. To address the questions of how often HSCs 
divide and, thus, possibly contribute simultaneously, sequen-
tially, or repetitively to steady-state hematopoiesis, of whether 
there is a relationship between divisional history and blood 
forming or repopulating ability, and if HSC self-renewal is 
increased in hematopoietic stress upon severe infectious chal-
lenge, we set up an in vivo HSC divisional tracking system using 
CFSE labeling.
RESULTS
In vivo CFSE dilution reveals steady-state divisional 
heterogeneity of Linc-kit+Sca-1+ (LKS) cells
Because 1% of HSCs are estimated to circulate in steady-
state blood, and some of them physiologically rehome into 
the 1% unoccupied BM HSC niches (Wright et al., 2001; 
Bhattacharya et al., 2006, 2009), we reasoned that i.v. transfer 
of HSC into nonirradiated mice resembles this process 
competitively and thus allows evaluation of steady-state HSC 
divisional dynamics. To track HSC division with high reso-
lution, we labeled cells with CFSE, a fluorescent dye which is 
HSCs would not contribute to relevant amounts of mature 
blood cells and could be a dormant reserve, only recruited 
upon hematopoietic challenge (Wilson et al., 2008; Foudi 
et al., 2009). However, the faster cycling HSCs repopulated 
lethally irradiated animals only in the short term, whereas the 
dormant HSCs showed long-term repopulation (Wilson et al., 
2008; Foudi et al., 2009). Therefore, these findings face diffi-
culty in explaining how high-throughput hematopoiesis is 
maintained by only a small HSC fraction with long-term po-
tential but a very slow division rate. An alternative explana-
tion would be that a single steady-state HSC pool exists that 
contains stochastically changing slow and fast dividing HSCs, 
with most HSCs within the pool dividing longitudinally at 
similar rates.
Although in steady-state adult mice more than two-thirds 
of HSCs are in a resting, i.e., G0/G1 phase of cell cycle 
(Cheshier et al., 1999), HSC division can be induced in situa-
tions of hematopoietic challenge, for example, chemother-
apeutic treatment, irradiation, and BM transplantation (Trumpp 
et al., 2010). Recently, it was demonstrated that HSC- 
enriched populations express Toll-like receptors (TLRs), which 
recognize bacterial or viral molecules, and that TLR ligation 
causes proliferation and enhances production of innate im-
mune cells such as macrophages and dendritic cells for respec-
tive host defense (Nagai et al., 2006; Massberg et al., 2007). 
Figure 1. Steady-state divisional heterogeneity of LKS cells revealed by in vivo CFSE dilution. (A) Representative dot plots of BM gated on  
donor CD45+Lin (top) and spleen gated on donor CD45+ CD4+CD62L+ (bottom) cells at the indicated time points after transplantation of CFSE-labeled 
LKS cells and CD4+CD62L+ cells into nonirradiated mice, respectively. Dashed lines represent CFSE intensity of CD4+CD62L+ cells indicating zero division.  
(B) Comparison of in vivo CFSE dilution and BrdU labeling. Dot plots and histograms show representative CFSE-labeled donor LKS cells 3 wk after trans-
plantation and after 2 wk of in vivo BrdU labeling and control, respectively. Dashed lines illustrate single divisions. (C) Mathematical model of three LKS 
subpopulations fitting the CFSE labeling data. See also Materials and methods.
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0×-divided non–BrdU-labeled LKS. These data demonstrate 
that CFSE labeling provides high-resolution single-division 
HSC tracking and reveal that BrdU labeling alters cell cycle 
kinetics but, as expected, does not mark the remaining quies-
cent cells. This fact might have had a profound impact on 
readout and interpretation of previous studies using the BrdU 
labeling and chase assay to evaluate HSC turnover, as cells are 
recruited into division and only recently divided and labeled 
cells are subsequently monitored, and most 0×-divided quies-
cent cells are not included in the chased population (Cheshier 
et al., 1999; Wilson et al., 2008).
To estimate the turnover and loss rate of total LKS cells, 
i.e., a population which contains but is not exclusively com-
posed of HSCs (Osawa et al., 1996b), we developed mathe-
matical models assuming that the LKS cell population is 
composed of one, two, three, or four subpopulations with dif-
fering rates of proliferation and loss. Fitting these mathemati-
cal models to the CFSE dilution data revealed at least three 
subpopulations with different division and differentiation ki-
netics (see Materials and methods and Table S1). One popula-
tion was characterized by a high rate of loss and no proliferation, 
and the remaining two populations roughly correspond to 
the fast-cycling and dormant populations identified previ-
ously (Wilson et al., 2008; Foudi et al., 2009).
Expression of HSC and lineage-differentiation markers  
by LKS cells upon division
To correlate divisional history with HSC and progenitor cell–
associated surface marker expression, we analyzed lineage 
negative cells in BM 3 wk after transfer. 0–2×-divided donor 
Linc-kit+ cells were positive for Sca-1 (>98%) and the 
thrombopoietin receptor c-Mpl (>93%), both of which are 
equally distributed to daughter cells upon each cellular division 
(Weston and Parish, 1990; Lyons and Parish, 1994). CFSE la-
beling did not impair HSC function, as CFSE-labeled LKS 
cells containing HSCs successfully engrafted nonirradiated 
animals with stable chimerism of 1% over at least 20 wk 
(unpublished data). Transplantation of 105 LKS into nonirra-
diated mice revealed that 0×-divided Linc-Kit+ cells with an 
equivalent CFSE intensity to that of naive CD4+CD62L+  
T cells transferred to determine zero cell division CFSE in-
tensity. When mice were irradiated before LKS transfer, all 
donor-derived LKS cells had divided ≥5× in 3 wk and high 
BM and blood chimerism was established as expected (Fig. S1). 
Weekly BM analysis of nonirradiated recipient mice trans-
planted with CFSE-labeled LKS showed that most of the 
donor cells divided within 4 wk, whereas a small fraction did 
not divide over 21 wk, the longest period observed (Fig. 1 A). 
0×-divided cells were maintained in the BM, but not in the 
spleen, and included LKS cells with a CD150+ and CD34 
phenotype, which are reported to be highly enriched for 
quiescent HSC (Osawa et al., 1996a; Kiel et al., 2005; 
Fig. S2, A and B). These data demonstrate that in steady state 
the majority of LKS cells divide actively and a small fraction 
is quiescent.
To compare the HSC-tracking method established in this 
study with BrdU labeling (Cheshier et al., 1999; Kiel et al., 
2007), mice were treated with BrdU starting 1 wk after 
CFSE-labeled LKS cell transfer. BrdU treatment led to more 
LKS divisions, confirming a mitogenic effect of BrdU (Kiel 
et al., 2007; Wilson et al., 2008; Fig. 1 B). However, BrdU in-
corporation neither correlated linearly with divisions nor al-
lowed divisional resolution. Most importantly, BrdU did not 
recruit all LKS cells into division, leaving behind a fraction of 
Figure 2. Expression of HSC surface markers upon division of CFSE-labeled LKS cells in BM. (A) Representative dot plots gated on BM donor 
Linc-Kit+ cells depicting CFSE label versus Sca-1, c-Mpl, CD150, CD34, and Flt3 expression 3 wk after transplantation of 105 CFSE-labeled LKS cells into 
nonirradiated recipients. Dashed lines represent cutoff regarded as positive. 0 to ≥7 divisions (indicated at top of dot plots) were determined according to 
CFSE intensity. (B) Percentage of Linc-Kit+ cells, positive for indicated surface antigens within total host or 0–2×-, 3–6×-, and ≥7×-divided donor popu-
lations (shown in A). Mean ± SD is shown (n = 4–6 from three to six independent experiments for each stain). *, P < 0.05; ***, P < 0.001.
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Figure 3. HSCs have heterogeneous divisional activity. (A) Experimental scheme of sequential transplantation. (B) Representative dot plots of 
BM from primary LKS transplant recipients gated on donor Linc-Kit+ cells. Sorting gate for 0×- (red, orange, and pink) and ≥5×-divided LKS cells 
(light blue, dark blue, and purple) are shown at the indicated time points after primary transplantation. (C–E) PB donor chimerism in indicated popu-
lations after secondary transplantation with single 0×-divided LKS cells (C and D) or 10–250 ≥5×-divided LKS cells (E). (C) Representative PB FACS dot 
plots 16 wk after secondary transplantation with a single 0×-divided LKS cell sorted from primary recipients at 3 wk after LKS transfer. (D) Each line 
represents sequential data from individual animals (n = 18–21 mice as indicated from four to five independent experiments). Asterisk shows engraft-
ment data of the animal shown in C. Range of donor CD45+ chimerism in engrafted mice 4 mo after secondary transplantation: 32.7–72%, 1.8–
22.5%, and 1.0–19.9% in mice transplanted with LKS cells isolated 3, 7, and 12/14 wk after primary transplantation, respectively. (E) Lines represent 
all data from four independent experiments with SD error bars (number of mice in each group are indicated at each line). (F) Long-term engraftment 
of 0×- or ≥5×-divided LKS cells in secondary and tertiary transplants. Donor chimerism in total CD45+ cells, myeloid cells, and LKS cells in BM was 
examined 32–44 wk after secondary transplantation (black dots) and 20 wk after tertiary transplantation (gray dots). Each connecting line shows data 
derived from identical primary donor cells. Arrows represent increase in contribution to hematopoiesis after tertiary transplantation. Dashed line at 
0.1% marks cut off determined for nonengraftment.
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highly expressed in HSC (Spangrude et al., 1988; Qian et al., 
2007; Yoshihara et al., 2007), and their expression decreased 
with division. 40–50% of 0–2×-divided cells were positive for 
CD150 (Kiel et al., 2007) and negative for CD34 (Osawa 
et al., 1996a), and Fms-like tyrosine kinase 3 (Flt3) expression 
(Christensen and Weissman, 2001; Karsunky et al., 2003) was 
low in 0–2×-divided and up-regulated in 3–6×-divided cells 
(Fig. 2). Some Linc-Kit+ cells started to express markers of 
lineage commitment like M-CSFR (Onai et al., 2007), IL-7R 
(Kondo et al., 1997), and FcRII/III (Akashi et al., 2000; 
Kondo et al., 2003) after more than three divisions (Fig. S2, 
C and D). Thus, surface marker expression pattern analysis 
demonstrates that at 3 wk after transfer, 0–2×-divided cells 
displayed a HSC immunophenotype. Furthermore, LKS cell 
differentiation to lymphoid or myeloid lineage-committed 
progenitors required at least three divisions in steady state.
Heterogeneous cycling activity of functional HSCs
As HSCs represent a minority within LKS cells (Osawa et al., 
1996b) and LKS cell division does not necessarily reflect HSC 
divisional dynamics, we determined HSC frequency by in vivo 
single-cell and limiting dilution repopulation and serial 
transplantation assays. We reisolated defined numbers of 
donor LKS cells based on their divisional history at different 
time points after primary transfer (Fig. 3 B) and transplanted 
these into lethally irradiated secondary recipient mice along 
with irradiation-protective whole BM cells, followed by 
monthly analysis for donor engraftment (Fig. 3 A). Transplan-
tation of single 0×-divided LKS cells, isolated 3–14 wk after 
primary transplantation, yielded multilineage reconstitution 
in 22–28% of irradiated mice for 16 wk (Fig. 3, C and D; 
Table I; and Fig. S3). Up to 250 LKS cells that had divided 
≥5× in 3 wk in primary recipients showed no engraftment, 
whereas 50–250 ≥5×-divided LKS cells at 7 or 12–14 wk 
after primary transfer contained long-term multilineage re-
populating HSCs (Fig. 3 E, Table I, and Fig. S3). Based on in 
vivo limiting dilution transplantation, the frequency of HSC 
in ≥5×-divided LKS cells at 7 and 12–14 wk was 1:293 and 
1:153, respectively (Fig. S3 D). BM LKS CD34 cell analysis 
revealed maintenance of donor chimerism within this HSC-
enriched cell fraction over 6 mo (Fig. S4).
We next tested serial long-term hematopoietic potential 
of 0×- and ≥5×-divided LKS cells by transferring whole BM 
cells from engrafted secondary recipients into lethally irradi-
ated tertiary recipient mice (Fig. 3 A). Both 0×- and ≥5×- 
divided LKS cells were able to reconstitute BM compartments 
of irradiated mice for a total of 52–64 wk, i.e., >1 yr, over se-
rial transplantation. Donor chimerism varied depending on 
individual mice but not on divisional history of donor cells 
from primary transplants (Fig. 3 F). Given that noncondi-
tioned i.v. transfer reflects steady-state physiological HSC cir-
culation and BM rehoming (Wright et al., 2001; Bhattacharya 
et al., 2006; Méndez-Ferrer et al., 2008), these findings, in 
contrast to previous studies (Wilson et al., 2008; Foudi et al., 
2009), directly demonstrate cycling heterogeneity in steady-
state HSC; some HSCs are quiescent over months and con-
sequently do not contribute to blood production, whereas 
others possess high cycling activity and, thus, likely contribute 
to blood cell production during this time.
To determine the mean turnover rate of HSC, we calcu-
lated the number of HSC in division classes 0 and ≥5 from the 
repopulation assay data (Fig. 4 A and Table S2) and fitted a 
mathematical model to the number of HSC, assuming that 
their division rate is equal to the rate of loss, and, hence, the 
total HSC number in this steady-state model is constant over 
time (see Materials and methods). We estimate that HSCs di-
vide, on average, every 39 d (95% confidence interval 20–50 d), 
leading to a total of 18 divisions during a lifetime of a 
mouse. As there was no statistical evidence for heterogeneous 
division rates in the functional biologically defined HSC 
population, this indicates that HSCs with long-term reconsti-
tution capacity are not necessarily permanently split into sub-
populations with different cycling kinetics (Wilson et al., 2008; 
Foudi et al., 2009).
Table I. Transplantation of 0×-, 0–2×-, or ≥5×-divided LKS cell into lethally irradiated mice reveals steady-state cycling 
heterogeneity in HSC
Cells injected Cell dose Secondary recipient mice with long-term multilineage reconstitution
Sorting time points after primary transplantation
Week 3 Week 7 Week 12/14
0×-divided 1 24 (5/21) 22 (4/18) 28 (5/18)
0–2×-divided 10 67 (4/6) 100 (5/5) ND
0–2×-divided 20 100 (7/7) ND ND
≥5×-divided 10 0 (0/4) 0 (0/5) 11 (1/9)
≥5×-divided 20 0 (0/7) 0 (0/7) 10 (1/10)
≥5×-divided 50 0 (0/7) 20 (1/5) 36 (4/11)
≥5×-divided 250 ND 67 (2/3) 71 (5/7)
The indicated numbers of LKS cells at the indicated time points after primary transplantation were deposited into individual wells of 96-well plates. The contents of each well 
were injected into lethally irradiated animals along with 2 × 105 total BM cells. After 4 mo, PB of transplanted mice was analyzed on flow cytometry to identify mice that were 
multilineage reconstituted by donor cells (above background: >0.1% in B220+, CD3+, and B220CD3CD11b+Gr-1+ cells). The numbers in the time point columns represent 
the percentage of engrafted mice, and the parenthetical numbers represent the number of engrafted mice per number of transplanted mice. ND, not determined.
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indicates that some HSC clones or their offspring vary in 
contribution to blood production over time. This is consistent 
with recent publications indicating reactivation of HSCs from 
quiescence over time (Morita et al., 2010).
To address the question of whether divisional frequency is 
kept constant or if steady-state fast-dividing LKS cells natu-
rally vary turnover rates, we performed steady-state serial 
transplantation with fast-cycling cells. 4,000–6,500 LKS cells 
that had divided ≥5× at 14 wk after primary transplantation 
were reisolated, labeled again with CFSE, and subsequently 
transplanted into secondary nonirradiated animals (Fig. 4 B). 
Assuming constant divisional frequency, transferred cells 
should divide at least ≥2× within 6 wk. However, some donor 
LKS cells remained in the zero- or onefold division, demon-
strating that fast-cycling cells or their progeny can slow down 
the divisional rate in steady state (Fig. 4 C).
Increased dormancy of aged LKS CD150+ and expanded  
LKS cells
Next, we examined whether steady-state aging or massive he-
matopoietic system expansion after lethal irradiation and BM 
Changing divisional frequencies of LKS cells revealed  
by steady-state serial transplantation
Virus-mediated HSC marking suggested that hematopoiesis 
is maintained by stem cell clones that asynchronously self- 
renew and differentiate (Lemischka et al., 1986; McKenzie 
et al., 2006). Consistent with those findings, our serial trans-
plantation experiments showed that the donor contribution 
to mature blood cells and LKS cells varied and increased in 
some tertiary recipients (Fig. 3 F, arrowheads). Secondary and 
tertiary recipients contained blood-forming cells derived 
from single 0×-divided HSCs and, according to limiting dilu-
tion transplantation experiments, single or double ≥5×-divided 
HSCs. Thus, the fluctuating hematopoietic contribution 
Figure 4. Maintenance of biologically defined HSCs over time and 
steady-state serial transplantation revealing changing divisional fre-
quencies of LKS. (A) Mathematically calculated mean number of 0×- or 
≥5×-divided biologically defined HSCs per mouse over time based on en-
graftment data described in Materials and methods and Table S2. (B) Experi-
mental scheme of steady-state serial transplantation of cycling LKS cells 
into nonirradiated mice. (C) Representative dot plots of BM from secondary 
transplants gated on donor (CD45.2+) or host (CD45.1/2+) Lin cells at 6 wk 
after secondary transplantation. Dashed lines represent zero division.
Figure 5. Increased dormancy of LKS CD150+ cells associated 
with steady-state aging. (A) Experimental scheme of transplantation. 
Young mice were transplanted with 7.5–10 × 104 CFSE-labeled LKS cells from 
young (8–12 wk old) or aged (64–72 wk old) mice and analyzed after 4 wk.  
(B) Representative dot plot analysis of lineage-depleted BM gated on donor 
Lin cells. Dashed lines represent zero division. Number of donor LKS CD150+ 
cells having undergone indicated numbers of divisions were calculated. Graph 
shows mean ± SD (n = 3 mice from two to three independent experiments).
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subsequently, undergo division at peripheral sites 
to give rise to innate immune cells (Nagai et al., 
2006; Massberg et al., 2007). However, there is no 
direct evidence that quiescent HSCs in BM increase 
division and self-renewal to contribute to blood 
cell production upon demand in vivo. We tested 
if LPS challenge, as a surrogate for gram-negative 
infection which induces massive myeloid cell pro-
duction, would recruit quiescent HSCs into cycle. 
Mice that had been previously transplanted with 
CFSE-labeled LKS cells were repetitively treated 
with LPS and analyzed 8 d after final LPS injection 
(Fig. 6 A). Although 0×-divided control T cells 
were detectable, 0×-divided LSK cells were absent, 
and the number of ≥5×-divided LKS cells was in-
creased in LPS-treated mice (Fig. 6, B and C), in-
dicating cell loss or recruitment of LKS cells into cell cycle. 
To evaluate HSC potential in 2–4×- or ≥5×-divided LKS 
cells from PBS- or LPS-treated mice, cells were reisolated 
and transplanted into lethally irradiated secondary recipi-
ents (Fig. 6 A). 4 mo after transplantation, donor chime-
rism in peripheral blood (PB) and contribution to different 
lineage cells were examined. Consistent with previous ex-
periments (Fig. 3 E), donor cell engraftment was rarely de-
tected in secondary recipients transplanted with 2–4×- and 
≥5×-divided LKS cells from PBS-injected control mice. 
In marked contrast, both 2–4×- and ≥5×-divided LKS cells 
from LPS-injected mice contributed to the generation of 
multilineage hematopoiesis in more than half and in some 
of the recipients, respectively, after 16 wk (Fig. 6 D). Line-
age distribution analysis in secondary transplanted animals 
showed no lineage-biased repopulation, indicating that LPS 
challenge does not affect cell fate or differentiation potential 
of HSC (unpublished data). Thus, this data provides the first 
evidence that a naturally occurring hematoimmunological 
challenge, such as gram-negative bacterial infection, induces 
transplantation with low HSC numbers, i.e., both states with 
overall increased HSC divisional history, affects cell cycle kinet-
ics of HSC-enriched cells. CFSE-labeled LKS cells from aged 
and young mice were transplanted into steady-state young mice. 
The frequency and number of 0×-dividing or slow-dividing 
LKS CD150+ was substantially increased in mice transplanted 
with aged cells (Fig. 5, A and B). Similarly, CFSE-labeled LKS 
cells from mice that were transplanted 16 wk previously with 
low numbers of HSCs showed an increased ratio of slow- 
dividing and quiescent to fast-dividing cells (unpublished data). 
This data demonstrates that LKS cells, containing HSCs with 
an increased divisional history, have a tendency to return to 
quiescence. If this reflects a general biological feature of HSCs, 
steady-state fast-dividing HSCs will slow down their divisional 
rate, once given the opportunity in a permissive environment.
Recruitment of HSC into division upon in vivo  
LPS challenge
Immunophenotypically defined HSCs have been shown to 
recognize viral or bacterial components through TLRs and, 
Figure 6. In vivo LPS challenge recruits HSCs into divi-
sion. (A) Experimental scheme of transplantation and LPS 
challenge. (B) Representative dot plots gated on donor Lin 
cells from BM of primary transplant recipients at day 21 after 
transfer of CFSE-labeled LKS cells with or without four injec-
tions of LPS. Sorting gates for 0×- (red), 2–4×- (green), or 
≥5×-divided LKS cells (blue) are shown. Dashed lines represent 
zero division. (C) Representative dot plots gated on donor 
CD4+CD62L+ cells from spleen of primary transplant recipients 
at day 21 after transfer of CD4+CD62L+ cells with or without 
four injections of LPS . Dashed lines represent zero division.  
(D) PB donor engraftment within myeloid, T, and B cells 4 mo 
after secondary transplantation with 20 2–4×- or ≥5×-divided 
LKS cells from PBS- or LPS-treated mice (B). Pooled data from 
three independent experiments are shown as dots (represent-
ing one mouse each) and a bar graph depicting mean ± SD. 
Orange dots show the multilineage reconstituted animals. 
Black dots show animals with one or zero lineages reconsti-
tuted. The dashed line at 0.1% shows background threshold 
set for engraftment cutoff. ND, not detected.
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HSC function (Allsopp et al., 2001). HSC cycling activity is 
a result of extrinsic and intrinsic regulation (Orford and 
Scadden, 2008). Based on our data, we would like to suggest that 
steady-state fast-cycling or enhanced turnover with aging or 
irradiation- and transplantation-induced proliferation might 
activate an intrinsic HSC program that, based on divisional 
history, drives toward quiescence. Thus, an intrinsic cell mem-
ory effect to prevent HSC exhaustion might be counter-
balanced by an extrinsic drive for proliferation. The underlying 
mechanisms will need to be determined in the context of en-
vironmental cues such as availability of adhesion molecules 
and growths factors in the putative BM HSC niche.
Third, we show that in vivo TLR4 agonist challenge re-
cruits in vivo functional quiescent HSCs into proliferation 
and self-renewal with nonbiased lineage repopulation capacity. 
Although TLR ligation on HSCs has been shown to induce 
cellular division and myeloid lineage-skewed differentiation 
ex vivo, there was no direct evidence for enhanced self- 
renewal of HSC in BM (Nagai et al., 2006; Massberg et al., 
2007). It is not clear from our experiments if LPS executes its 
effect on cell cycle regulation directly via TLR4 expressed on 
HSCs, via an indirect pathway, or via a combination of both. 
Hematopoietic and nonhematopoietic cell–secreted interfer-
ons have been recently identified by several studies to drive 
HSC in cycle upon artificial addition or in chronic infection 
(Essers et al., 2009; Sato et al., 2009; Baldridge et al., 2010). 
Our study extends these findings and directly demonstrates 
that correlates of gram-negative infections, or possibly self-
damage (Rakoff-Nahoum and Medzhitov, 2009), can signal 
from the periphery to primary hematopoietic sites in BM and 
have an impact on divisional behavior of HSCs. This mecha-
nism likely allows adequate hematopoietic responses and, at 
the same time, prevents loss of HSCs by differentiation.
Our mathematical simulation reveals that HSCs with dif-
ferent cycling activity can be contained in one HSC popula-
tion with relatively broad cycling variation and that, on 
average, HSCs divide 18× during a 2-yr lifespan of a labora-
tory mouse. Two principle models have been posed for the 
maintenance of hematopoiesis by stem cells. The clonal main-
tenance model suggests that all HSCs give rise to mature 
blood cells continuously throughout life and, thus, all HSCs 
should divide similarly to produce cells that contribute to 
blood formation (Fig. S5 A; Jordan and Lemischka, 1990; 
Cheshier et al., 1999; McKenzie et al., 2006; Kiel et al., 2007; 
Nygren and Bryder, 2008). The clonal succession model pro-
poses that some HSCs divide frequently, contribute to hema-
topoiesis, and fully differentiate or die subsequently and are 
followed by previously quiescent HSCs that then meet the 
same fate (Fig. S5 B; Kay, 1965; Drize et al., 1996; Wilson 
et al., 2008; Foudi et al., 2009). Based on our data, we suggest 
a “dynamic repetition” model, where some HSCs dominate 
blood formation for a time, subsequently enter a quiescent 
state in which other HSCs increase hematopoietic contribu-
tion, and get reactivated again and contribute to blood forma-
tion in repetitive cycles (Fig. S5 C). Our data do not suggest 
how long active and resting phases might last or how many 
proliferation and self-renewal of HSCs, a mechanism which 
might have evolved to enhance fitness to rapidly amplify 
innate immune responses upon demand.
DISCUSSION
Using a newly established HSC tracking method that utilizes 
in vivo CFSE dilution, we communicate three major findings 
on HSC turnover and contribution to blood formation in 
steady state and upon inflammation. The first finding is that in 
steady state, HSCs with equivalent life-long multilineage re-
population potential are contained in both frequently cycling 
cell populations that divide ≥5× in 7 wk, i.e., about every 
1.4 wk, and in quiescent cells that do not divide over 14 wk. 
The finding is not consistent with the previous observations that 
only quiescent cells possess serial reconstitution capacity and 
fast-diving cells have limited self-renewal (Wilson et al., 2008; 
Foudi et al., 2009). This contradiction might arise from techni-
cal issues, as numbers of cells transferred into secondary trans-
plants, and from sensitivity and resolution of divisional tracking 
methods. Another possibility would be that the dividing HSCs 
are not included in the population with LKS CD48CD150+ 
phenotype as subsets of HSC might not express CD150 
(Weksberg et al., 2008). Although it was assumed that both 
BrdU incorporation and H2B-GFP transgenic animal models 
allow us to follow seven cellular divisions, our comparative 
analysis demonstrates that staining intensity for BrdU detection 
reaches a limit at two to three divisions and that BrdU staining 
is not linear, suggesting a lower divisional resolution of BrdU 
retention than expected, whereas, in contrast, CFSE dilution 
can distinguish at least five divisions with high resolution. Fur-
thermore, the fact that BrdU has mitogenic activity, which has 
been shown in this paper and previously (Kiel et al., 2007; Wil-
son et al., 2008), has a substantial impact on the experimental 
readout because BrdU labeling changes cell cycle state as well 
as, potentially, consecutive function of cells. Also, most quies-
cent 0×-dividing HSCs are ignored in the BrdU assay, as our 
data shows remaining CFSE-high cells that do not incorporate 
BrdU. Thus, with some HSCs being deeply quiescent and 
inactive in DNA replication and protein synthesis, uniform 
labeling of all HSC by DNA labeling or marker protein ex-
pression might not be achieved at the starting point of chase. 
This contrasts with the CFSE labeling established in this paper 
that ensures highly uniform labeling and high-resolution divi-
sional tracking of cells without impairing HSC function, inde-
pendent of cell cycle activity during the labeling process.
The second finding is that steady-state fast-cycling popu-
lations can slow down over time in steady-state serial trans-
plantation and that LKS CD150+ cells containing HSCs with 
extensive proliferative history—i.e., HSCs that have gone 
through extended proliferation in aging or after in vivo chal-
lenge by transplantation—are prone to return to quiescence. 
As demonstrated in this paper, divisional activity is not associ-
ated with HSC function in young adult mice. Furthermore, 
HSCs have the capacity to engraft and constitute long-term 
hematopoiesis over several serial transplantations, indicating 
that high divisional history does not lead to immediate loss of 
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follows: APC-Cy7–conjugated c-Kit, PE-Cy7-conjugated anti–Sca-1, Pa-
cific blue–conjugated anti-CD45.1 (A20), APC-conjugated anti-CD45.2 
(104), PE-conjugated anti-CD150 (TC15-12F12.2; BioLegend), PE- 
conjugated anti-CD34 (Raw34), PE-conjugated anti-CD16/32 (2.4G2), 
PE-conjugated IL-7 (A7R34), PE-conjugated anti-Flt3 (A2F10.1), bioti-
nylated anti–c-Mpl (AMM2 donated by Kyowa Hakko Kirin Co., Ltd.), PE-
conjugated anti–M-CSFR (AFS98), or PE-Cy5–conjugated antilineage 
antibody. The biotinylated antibody was detected with PE-conjugated strep-
tavidin. Each single division was determined as follows: a gate for zero divi-
sion was set on the CFSE peak of the undivided naive T cell control, 
and subsequent divisions were determined according to reduced fluores-
cence intensity of peaks in respective histograms. The background fluores-
cence was determined from nontransplanted BM sample. For evaluation of 
peripheral engraftment, thymus, spleen, lymph nodes, and PB were harvested 
and stained with FITC-conjugated anti–Gr-1, PE-conjugated anti-CD11b, 
PE-Cy5–conjugated CD3, APC-Cy7–conjugated B220, PE-Cy7–conjugated 
CD45.1, and APC-conjugated CD45.2. Before analysis, cells were resus-
pended in PBS containing 2 µg/ml Hoechst 33342 (Invitrogen). The per-
centage of donor contribution was assessed by measuring CD45.1+ or CD45.2+ 
cells in B220+ B-lineage, CD3+ T-lineage, or B220CD3CD11b+Gr-1+ 
myeloid lineage cells. Cutoff for donor engraftment was determined based 
on the percentage of nonspecific stain in nontransplanted secondary trans-
planted recipient. All antibodies were purchased from eBioscience except 
when otherwise specified.
BrdU retention assay with CFSE labeling. 1 wk after transfer of CFSE-
labeled LKS cells into nonirradiated mice, animals were i.p. injected with a 
single dose of 180 µg BrdU (Sigma-Aldrich) and were fed water containing 
800 µg/ml BrdU and 5% glucose for the next 14 d. Mice were then sacrificed 
and BrdU staining was performed using a BrdU labeling kit (BD). Cells from 
PBS-treated animals were used as a negative control for BrdU staining.
Single cell and whole BM transplantation into lethally irradiated 
mice. 3–14 wk after primary transplantation with CFSE-labeled cells, Lin 
cells were immunomagnetically enriched from long bones of mice, as de-
scribed in Flow cytometric analysis and stained with antibodies to CD45.1, 
CD45.2, c-Kit, and Sca-1. 1–250 donor-derived LKS cells (CD45.2+) were 
sorted into individual wells of 96-well plates using a FACSAria. Single cell 
deposition was confirmed microscopically. 2 × 105 total BM cells from 
CD45.1+ or CD45.2+ mice were suspended in Mg2+/Ca2+-free Hank’s buff-
ered salt solution supplemented with 2% FBS and plated into each well. The 
content of each well was i.v. injected into mice that were lethally irradiated 
with 2 × 6.5 Gy in a 4-h interval. Mice were bled monthly, blood was sub-
jected to red blood cell lysis, and donor engraftment was analyzed as 
described in Flow cytometric analysis. Recipients with >0.1% donor chi-
merism in B-lineage (B220+), T-lineage (CD3+), and myeloid-lineage 
(B220CD3CD11b+Gr-1+) population was considered to be multilineage 
repopulated. The frequency of HSC in LKS cells at the indicated time points 
after primary transfer was determined according to Poisson statistics (Smith 
et al., 1991) or L-Calc (STEMCELL Technologies Inc.). For the tertiary 
transplantation, one to three million cells of total BM cells harvested from 
secondary transplants were injected into lethally irradiated mice (CD45.1+  
or CD45.2+).
Statistical analysis. The significance of differences was determined by an 
unpaired Student’s t test.
Mathematical modeling and analysis of LKS cell division kinetics. 
The simplest model that can be used to describe the division kinetics of 
CFSE-labeled cells is given by the following differential equations (De Boer 
et al., 2006):
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HSC clones at any given time contribute to hematopoiesis. 
However, the model of steady-state reversible change between 
proliferation and quiescence in HSCs over time is consistent 
with virtual single cell–based simulation models (Glauche 
et al., 2009). Furthermore, the dynamically changing cycling 
activity likely results in a similar turnover of the entire HSC 
pool, indicating a homogeneous divisional history for all 
HSCs at the end of life, a suggestion which would be coher-
ent with linear telomere shortening observed in the human 
aging HSC pool (Rufer et al., 1999). The findings reported in 
this paper might represent a biological principle that could 
hold true for other somatic stem cell–sustained organ systems 
and might have developed during evolution to ensure equal 
distribution of work load, efficient recruitment of stem cells 
during demand, and reduction of risk to acquire genetic al-
terations by alternating fractions of stem cells in quiescence at 
any given time.
MATERIALS AND METHODS
Mice. C57BL/Ka-Thy1.1 (CD45.1+ or CD45.2+) mice were bred and 
maintained at the Institute for Research in Biomedicine animal facility. 
CD45.1/2+ F1 mice were generated by crossbreeding. 8–12-wk-old or 64–
72-wk-old mice were used in the studies. Mice were treated in accordance 
with the guidelines of the Swiss Federal Veterinary Office, and experiments 
were approved by the Dipartimento della Sanità e Socialità and Gesundheits-
direktion Kanton Zürich, Veterinäramt.
Cell isolation and sorting. Total BM cells were harvested from long bones, 
red blood cells were lysed with ACK lysis buffer (150 mM NH4Cl, 10 mM 
KHCO3, and 0.1 mM EDTA), and debris was removed with 70-µm cell 
strainers (BD). Cells were stained with PE-Cy5–conjugated antibodies 
against the lineage antigens B220 (RA3-6B2), CD3 (145-2C11), Ter119 
(Ter119), and Gr-1 (RB6-8C5) and immunomagnetically enriched for lineage-
negative cells using anti-Cy5/anti–Alexa Fluor 647 Microbeads (Miltenyi 
Biotec). The lineage-depleted cells were subsequently stained with allophy-
cocyanin (APC)-Cy7–conjugated antibody to c-Kit (2B8) and FITC- 
conjugated antibody to Sca-1 (D7), and LKS or Linc-Kit+Sca-1 (LK) cells 
were sorted using a FACSAria (BD). Naive CD4+CD62L+ T cells were 
enriched from spleen cells with PE-Cy5–conjugated anti-CD4 antibody 
(GK1.5) and anti-Cy5/anti–Alexa Fluor 647 Microbeads, and were then 
stained with PE-conjugated anti-CD62L antibody (MEL-14) followed by 
sorting of CD4+CD62L+ cells on a FACSAria. All antibodies were obtained 
from eBioscience.
CFSE staining and cell transplantation into nonirradiated or suble-
thally irradiated mice. Sorted cells were labeled for 7 min at 37°C with 
2 µM CFSE (Invitrogen) in Dulbecco’s PBS (D-PBS; Invitrogen) supple-
mented with 2% FBS (Invitrogen). The same volume of ice-cold D-PBS with 
10% FBS was then added to stop the reaction. After wash with Mg2+/Ca2+-
free PBS, 105 CFSE-labeled LKS cells (CD45.2+) or 2 × 106 CFSE-labeled 
CD4+CD62L+ naive T cells (CD45.2+) were i.v. transplanted into nonirradi-
ated recipient F1 (CD45.1/2+) mice. In some cases, mice were sublethally 
irradiated with 6.5 Gy from a Cesium 137 source (BIOBEAM 8000; STS 
GmbH) at 3.75 Gy/min before transplantation.
In vivo LPS challenge. 105 CFSE-labeled LKS cells were transplanted into 
nonirradiated animals. 1 wk after transplantation, mice were i.p. injected with 
PBS or 35 µg LPS from Escherichia coli (Ultrapure; InvivoGen) 4×, each with 
a 2 d-interval, and were analyzed 6 d after the final injection.
Flow cytometric analysis. Lineage-negative cells from BM were enriched 
from transplanted mice and stained with additional monoclonal antibodies as .
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We fitted Eqs. 4 and 5 to the normalized cell counts by minimizing the 
squared difference between log-transformed normalized cell counts and the 
predictions of Eqs. 4 and 5. We found that the two-subpopulation model fits 
significantly better than the one-subpopulation model (F-test, df1 28= ,
df2 26= , P = 2.2 × 104). Thus, there is a strong statistical signal that the LKS 
cell population is heterogeneous with respect to its differentiation rate. The 
best estimates for the parameters of Eq. 5 are:
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The death rates correspond to a mean life-span of 3.8 and 55 d, respec-
tively. (Fitting Eq. 4, we obtain d = (0.254 ± 0.020)/wk.)
In the next step, we fitted the full two- and three-subpopulation model 
and estimated the remaining parameters of these models. The fitting routine 
involved minimizing the squared difference between log-transformed LKS 
cell counts and the predictions of the two- or three-subpopulation models. 
The last division class, five and greater, was omitted in the fitting procedure 
because we found, on the basis of simulated data, that omitting the last divi-
sion class resulted in less biased parameter estimates. We found that there is 
evidence for at least three subpopulations in the data. A three-subpopulation 
model, assuming Poisson division and loss of LKS cells, fits significantly better 
than a model assuming two subpopulations (F-test, df1 153= , df2 150= , P = 
2.4 × 1014). Estimates of the parameters that characterize the three subpop-
ulations are listed in Table S1. Hereby, f1, f2, and f3  are the initial fractions 
of subpopulation one, two, and three, respectively. λi is the division rate, and
di is the loss rate of the ith subpopulation (as a result of differentiation, loss of 
marker, or death). Thus, we have evidence for a subpopulation that is lost at 
the high rate of d wk1 1 8= . / and does not divide. Subpopulations two and 
three initially constitute 22 and 7.7% of the LKS population and divide once 
every 12 and 97 d, respectively. Subpopulations two and three correspond to 
the slowly and fast cycling subpopulations that were identified previously 
(Wilson et al., 2008; Foudi et al., 2009; van der Wath et al., 2009).
Mathematical modeling and analysis of division kinetics of biologi-
cally functional HSC. To estimate the turnover rate of biologically func-
tional HSC from the repopulation data, we first estimated the fraction of 
biologically functional HSC in the LKS cell population in division class zero 
and five or higher by a maximum likelihood procedure. If the fraction of 
biologically functional HSC is fHSC , and we transfer i LKS cells to m mice, 
the probability to observe repopulation of the hematopoietic system in r 
mice is:
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If we conduct E such repopulation experiments, the best estimate for the 
fraction of biologically functional HSC in the LKS population maximizes 
the following likelihood:
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In this expression, the variables mk or rk denote the number of mice used 
or repopulated in experiment k, respectively, and ik is the number of LKS cells 
transferred in experiment k.
We used the repopulation data to estimate the fraction of biologically 
functional HSC in division classes zero and five or higher at 3, 7, 12, and 
14 wk after primary transfer of the LKS cell population. Combining these esti-
mates with the number of LKS cells in each division class, we obtain an estimate 
Here, Xi denotes the number of LKS cells that gave undergone i divisions, 
and X5+ denotes the number of LKS cells that have divided five or more times. 
The parameter  is the rate constant for cell division, and d is the rate con-
stant for LKS cell loss. Several processes contribute to this loss of LKS cells. 
These are differentiation, which leads to a loss of LKS marker, cell death, or 
loss of LKS marker not related to differentiation. For simplicity, we refer to d as 
the differentiation rate constant. Because the experiment involved the trans-
fer of 5,000 CFSE-labeled LKS cells into the mice, we assume that at time t = 0, 
all cells are in the division class 0, corresponding to the highest CFSE label, 
and their number is X0 0 5 000( ) , .=  (In mathematical immunology, the division 
of cells is often described by the Smith-Martin model rather than this simple 
model above [De Boer et al., 2006]. The Smith-Martin model describes the 
cell cycle in more detail introducing a parameter for the time a cell re-
quires for dividing once it committed to division. However, because the di-
vision kinetics of LKS cells is very slow, occurring on the time scale of 
weeks rather than hours, the time required for cell division can be ignored.)
We constructed extensions of this basic model to study the hetero-
geneity of the division kinetics of the LKS populations. In particular, 
we developed versions of the basic model in which we assume two or 
three subpopulations, each with their own division and differentiation 
rates. These mathematical models are given by the following set of differ-
ential equations:
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Hereby, the parameter s denotes the subpopulation and is an integer 
ranging from 1 to the number of subpopulations considered in the model. 
We assume that at time t = 0, all cells are undivided and their number is
X s
s 0
0 5000( )( ) .∑ =  It is useful to define the initial fraction f s of undivided cells 
in the sth subpopulation by X f Xs s
s
s0 0
0 0( ) ( )( ) ( ).= ∑  Obviously, f ss∑ = 1.  
Unlike the models used in Wilson et al. (2008) and van der Wath et al. (2009), 
this model does not assume that fast-cycling cells arise from dormant cells by 
differentiation. Rather, we assume that each subpopulation is independently 
dividing and differentiating.
The most straightforward way to analyze the LKS CFSE cell data would 
be to successively fit the one-, two-, and three-subpopulation versions of the 
mathematical model and to assess if increasing the number of subpopulations 
increases the goodness of fit (as measured by the residual sum of squares) sig-
nificantly (as determined by an F-test). However, a straightforward fit of a 
model with more than one subpopulation, in which the parameters of the 
model are unconstrained, does not result in consistent goodness of fit and 
consistent parameter estimates. We have therefore adopted a two-step proce-
dure to estimate the parameters of the mathematical models. First, we esti-
mate the differentiation rates d of the first two subpopulations from the 
normalized cell counts (defined in Eq. 3). This leads to a constraint for the 
differentiation rates. Second, we estimate the division rates and the differenti-
ation rates of the remaining subpopulations from fitting the model to the 
LKS cell count in the different division classes.
Normalized cell counts are a way to eliminate the division kinetics from 
CFSE data (De Boer et al., 2006). The normalized cell count is defined as:
	 N t X ti i
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Assuming a single, homogeneous subpopulation, N(t) is an exponentially 
decaying function which is independent of the division rate :
	 N t N e dt( ) ( )= −0 .	 (4)
Thus, in a plot of ln(N(t)) versus the time, t, the slope is d. Assuming 
two subpopulations, N(t) is a bimodally decaying function that is indepen-
dent of the division rates λ1 and λ2 :
.
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for the number of biologically functional HSC in the division classes zero 
and five or higher. Table S2 shows these estimates.
We then used the homogeneous cell division model (Eq. 1) to estimate 
the turnover rate of biologically functional HSC. We assumed that the num-
ber of biologically functional HSC stays constant over the 14 wk. This con-
stant number of biologically functional HSCs can be interpreted as the 
number of stem cell niches that are occupied after the transfer of CFSE- 
labeled cells. Assuming a constant number of biologically functional HSCs is 
mathematically equivalent to setting the division rate equal to the rate of dif-
ferentiation or loss of biologically functional HSC.
We estimated a division rate of 0.18/wk, which corresponds to one divi-
sion every 39 d. The 95% confidence interval of this estimate is 0.14–0.35/wk, 
which corresponds to a range of one division every 20–50 d. This is 
strong evidence that biologically functional HSCs do not divide only every 
150 d, as has been suggested by other studies (Wilson et al., 2008; Wilson 
et al., 2009; Trumpp et al., 2010). The constant number of biologically func-
tional HSCs in the system (i.e., the number of occupied stem cell niches) is 
estimated as 388 cells (95% confidence interval: 193–559 cells).
We investigated whether relaxing some of the model assumptions alters 
the estimate of biologically functional HSC dramatically but found that the 
estimate of the turnover rate is robust. If we relax the assumption that the di-
vision rate equals the rate of differentiation and loss, we obtain a division rate 
of 0.26/wk, which lies within the 95% confidence interval of the estimate 
assuming equal division and differentiation rates. This means that the two es-
timates are not significantly different. If we set the number of niches to 200 
rather than estimating this quantity from the data, we obtain a division rate 
of 0.24/wk, which is, again, not significantly different from the estimate 
based on flexible number of niches. Lastly, a two-population model does not 
significantly improve the fit to the data on biologically functional HSC 
(Table S2): F-test, df1 29= , df2 27= , P = 0.15. Thus, there is no evidence for 
a heterogeneously dividing population of biologically functional HSC.
Implementation. All the mathematical models and the analysis described in 
the previous two sections were implemented in the R language of statistical 
computing (R Development Core Team, 2008).
Online supplemental material. Fig. S1 shows homogenous CFSE 
labeling and CFSE label–retaining cell populations upon nonconditioned 
transplantation of LKS but not LK. Fig. S2 shows 0×-divided cells that are 
maintained in BM, but not spleen, and included in LKS CD34CD150+ 
population. Fig. S3 shows donor contribution to lymphoid lineage in 
secondary transplantation with 0×- or ≥5×-divided LKS cells, and HSC 
frequency determined by limiting dilution transplantation. Fig. S4 shows 
donor chimerism in HSC-containing population in BM of secondary 
recipient reconstituted with 0–2×- or ≥5×-divided LKS cells. Fig. S5 
shows hypothetical models for steady-state hematopoiesis. Table S1 shows es-
timates of the parameters of the three-subpopulation model on LKS turnover. 
Table S2 shows estimate of biologically functional HSC. Online supplemen-
tal material is available at http://www.jem.org/cgi/content/full/jem 
.20101643/DC1.
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